C. Bilir Et Al. , "Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study," Cancer Investigation , vol.35, no.4, pp.248-255, 2017
Bilir, C. Et Al. 2017. Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study. Cancer Investigation , vol.35, no.4 , 248-255.
Bilir, C., YILDIZ, İ., BİLİCİ, A., Ucar, M., Berk, V., Yıldız, Y., ... Yazıcı, O.(2017). Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study. Cancer Investigation , vol.35, no.4, 248-255.
Bilir, Cemil Et Al. "Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study," Cancer Investigation , vol.35, no.4, 248-255, 2017
Bilir, Cemil Et Al. "Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study." Cancer Investigation , vol.35, no.4, pp.248-255, 2017
Bilir, C. Et Al. (2017) . "Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study." Cancer Investigation , vol.35, no.4, pp.248-255.
@article{article, author={Cemil Bilir Et Al. }, title={Is Change in Hemoglobin Level a Predictive Biomarker of Tyrosine Kinase Efficacy in Metastatic Renal Cell Carcinoma? A Turkish Oncology Group Study}, journal={Cancer Investigation}, year=2017, pages={248-255} }